In situ evidence for HPV 16, 18, 33 integration in cervical squamous cell cancer in Britain and South Africa.
about
Laboratory techniques in the investigation of human papillomavirus infection.Detection of Human Papillomavirus in Cervical Gradings by Immunohistochemistry and Typing of HPV 16 and 18 in High-Grades by Polymerase Chain Reaction.Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysisDetection of human papillomavirus in large cell neuroendocrine carcinoma of the uterine cervix: a study of 12 cases.Human papillomavirus status in the prediction of high-grade cervical intraepithelial neoplasia in patients with persistent low-grade cervical cytological abnormalities.Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation.Detection of human papillomavirus in matched cervical smears and biopsy specimens by non-isotopic in situ hybridisationIntegration of human papillomavirus types 16 and 18 in cervical adenocarcinoma.Detection of integrated high risk human papillomavirus in adenoid cystic carcinoma of the uterine cervixHuman papillomavirus, integration and cervical carcinogenesis: a clinicopathological perspectiveHuman papillomavirus and schistosomiasis associated bladder cancer.Role of human papillomavirus in determining the HLA associated risk of cervical carcinogenesisSeroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia.Seroresponses to virus-like particles of human papillomavirus types 16, 18, 31, 33, and 45 in San people of Southern Africa.
P2860
Q33933492-C4921743-8033-4B9F-9AF5-760DCBB2FA6CQ35137997-37874655-C600-4903-A9C7-06CEDBF1C124Q35413976-AF1127AA-D732-4AD4-A44C-C78CDD9CE458Q35586001-6ABDED61-57AA-441D-8989-2C595872E319Q36079862-2BE82087-C8DC-4840-B5AE-0450DC163675Q37105564-6FB4549C-E816-4B4D-AE7E-65A2D9D16A91Q37111544-840AF659-1547-4D8A-BFB0-8DCEE1F11973Q37111604-77857844-56C5-4E56-8C52-0C9634D316F0Q37223999-CBF782DF-3F27-4B92-BBA2-649D22C03F1DQ37227209-22AF358F-E108-4530-9413-B0F0748F384DQ37228353-343B0681-0175-4E27-B5E6-A20BC18460CEQ37254201-C842AF34-D912-41E6-82CA-EC198AD1DD49Q45744233-017CC2B8-D530-433E-B9EF-3F13695A9534Q45745124-A56943D8-0A9D-4E91-BC87-AFF934FF0EC8
P2860
In situ evidence for HPV 16, 18, 33 integration in cervical squamous cell cancer in Britain and South Africa.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In situ evidence for HPV 16, 1 ...... r in Britain and South Africa.
@en
In situ evidence for HPV 16, 1 ...... r in Britain and South Africa.
@nl
type
label
In situ evidence for HPV 16, 1 ...... r in Britain and South Africa.
@en
In situ evidence for HPV 16, 1 ...... r in Britain and South Africa.
@nl
prefLabel
In situ evidence for HPV 16, 1 ...... r in Britain and South Africa.
@en
In situ evidence for HPV 16, 1 ...... r in Britain and South Africa.
@nl
P2093
P2860
P356
P1476
In situ evidence for HPV 16, 1 ...... er in Britain and South Africa
@en
P2093
P2860
P304
P356
10.1136/JCP.44.5.406
P407
P577
1991-05-01T00:00:00Z